Also known as: ammonium lactate cream, Ammonium Lactate Cream
Ammonium lactate cream 12% is a topical dermatologic drug formulation containing lactic acid as ammonium lactate. It is used to treat xerosis and ichthyosis vulgaris and is applied to affected skin areas, typically twice daily. DailyMed labeling identifies this product as a human prescription drug marketed under an ANDA pathway.
Zydus Lifesciences received USFDA final approval for 32 mg bosentan tablets for pediatric PAH and Ammonium Lactate Cream, 12%, while launching an affordable respiratory device in India.
Zydus Lifesciences Limited received final FDA approval for Ammonium Lactate Cream, 12%, a generic of Lac-Hydrin Cream. The topical prescription medication treats xerosis and ichthyosis vulgaris, with annual U.S. sales of $15 million.
